Status:
UNKNOWN
A Study of Neurofeedback for the Treatment of Parkinson's Disease
Lead Sponsor:
Osaka University
Collaborating Sponsors:
Japan Agency for Medical Research and Development
Conditions:
Parkinson Disease
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
This study aims to reveal relationship between brain activities and the symptoms of Parkinson disease when a neurofeedback training was applied for them.
Eligibility Criteria
Inclusion
- Subjects with age more than 20
- Subjects obtained the consent
- Subjects with Parkinson disease and healthy subjects
Exclusion
- The subjects who can not conduct the tasks
- Subjects with severe illness
- Subjects whom the experimenter think as in appropriate
- Subjects with implantable devices such as pacemaker
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03837548
Start Date
June 1 2019
End Date
March 31 2022
Last Update
September 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka University
Suita, Osaka, Japan, 5650871